BRPI1014844A2 - variantes de hemaglutinina de influenza suína. - Google Patents
variantes de hemaglutinina de influenza suína.Info
- Publication number
- BRPI1014844A2 BRPI1014844A2 BRPI1014844A BRPI1014844A BRPI1014844A2 BR PI1014844 A2 BRPI1014844 A2 BR PI1014844A2 BR PI1014844 A BRPI1014844 A BR PI1014844A BR PI1014844 A BRPI1014844 A BR PI1014844A BR PI1014844 A2 BRPI1014844 A2 BR PI1014844A2
- Authority
- BR
- Brazil
- Prior art keywords
- influenza hemagglutinin
- swine influenza
- variants
- hemagglutinin variants
- swine
- Prior art date
Links
- 206010069767 H1N1 influenza Diseases 0.000 title 1
- 101710154606 Hemagglutinin Proteins 0.000 title 1
- 208000009620 Orthomyxoviridae Infections Diseases 0.000 title 1
- 101710093908 Outer capsid protein VP4 Proteins 0.000 title 1
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 title 1
- 101710176177 Protein A56 Proteins 0.000 title 1
- 239000000185 hemagglutinin Substances 0.000 title 1
- 201000010740 swine influenza Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16171—Demonstrated in vivo effect
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22042609P | 2009-06-25 | 2009-06-25 | |
| US22798609P | 2009-07-23 | 2009-07-23 | |
| US23402109P | 2009-08-14 | 2009-08-14 | |
| US25889009P | 2009-11-06 | 2009-11-06 | |
| PCT/US2010/039826 WO2010151673A1 (en) | 2009-06-25 | 2010-06-24 | Swine influenza hemagglutinin variants |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1014844A2 true BRPI1014844A2 (pt) | 2019-09-24 |
Family
ID=43386887
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1014844A BRPI1014844A2 (pt) | 2009-06-25 | 2010-06-24 | variantes de hemaglutinina de influenza suína. |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US8088393B2 (OSRAM) |
| EP (1) | EP2448598B1 (OSRAM) |
| JP (1) | JP5745511B2 (OSRAM) |
| KR (1) | KR20120101318A (OSRAM) |
| CN (1) | CN102802666B (OSRAM) |
| AU (2) | AU2010266078B2 (OSRAM) |
| BR (1) | BRPI1014844A2 (OSRAM) |
| CA (1) | CA2766377A1 (OSRAM) |
| MX (1) | MX2012000123A (OSRAM) |
| NZ (2) | NZ617191A (OSRAM) |
| RU (1) | RU2560420C2 (OSRAM) |
| SG (2) | SG176178A1 (OSRAM) |
| WO (1) | WO2010151673A1 (OSRAM) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2560420C2 (ru) | 2009-06-25 | 2015-08-20 | МЕДИММЬЮН, ЭлЭлСи | Варианты гемагглютининов вируса свиного гриппа |
| EP2764015A1 (en) * | 2011-10-07 | 2014-08-13 | Medlmmune, LLC | Influenza hemagglutinin variants |
| KR101315273B1 (ko) * | 2012-10-29 | 2013-10-08 | 대한민국 | 강독화된 인플루엔자 바이러스 변이주 |
| US9708585B2 (en) * | 2012-12-03 | 2017-07-18 | Seqirus UK Limited | Influenza virus reassortment |
| JP6974943B2 (ja) * | 2014-05-13 | 2021-12-01 | ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア | ２種の抗体構築物を発現するａａｖを含む組成物およびこの使用 |
| US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
| US10676723B2 (en) | 2015-05-11 | 2020-06-09 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| US11535665B2 (en) | 2015-05-13 | 2022-12-27 | The Trustees Of The University Of Pennsylvania | AAV-mediated expression of anti-influenza antibodies and methods of use thereof |
| US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
| JOP20190200A1 (ar) | 2017-02-28 | 2019-08-27 | Univ Pennsylvania | تركيبات نافعة في معالجة ضمور العضل النخاعي |
| WO2018160573A1 (en) | 2017-02-28 | 2018-09-07 | The Trustees Of The University Of Pennsylvania | Influenza vaccines based on aav vectors |
| WO2018160582A1 (en) | 2017-02-28 | 2018-09-07 | The Trustees Of The University Of Pennsylvania | Adeno-associated virus (aav) clade f vector and uses therefor |
| CN111511397A (zh) | 2017-12-22 | 2020-08-07 | 科达金尼克斯有限公司 | 具有密码子对去优化区域的重组病毒及其用于治疗癌症的用途 |
| CN112040977A (zh) | 2018-03-08 | 2020-12-04 | 科达金尼克斯有限公司 | 减毒黄病毒 |
| WO2025081053A1 (en) * | 2023-10-11 | 2025-04-17 | Flugen, Inc. | Formulations for thermostable vaccines |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7871626B2 (en) * | 2005-08-04 | 2011-01-18 | St. Jude Children's Research Hospital | Modified influenza virus for monitoring and improving vaccine efficiency |
| US8354114B2 (en) * | 2005-10-17 | 2013-01-15 | Medimmune, Llc | Multi plasmid system for the production of influenza virus |
| AU2007286161B2 (en) * | 2006-08-09 | 2013-05-02 | Medimmune, Llc | Influenza hemagglutinin and neuraminidase variants |
| MX2009013008A (es) * | 2007-05-31 | 2010-06-09 | Vacunas para la influenza. | |
| RU2560420C2 (ru) | 2009-06-25 | 2015-08-20 | МЕДИММЬЮН, ЭлЭлСи | Варианты гемагглютининов вируса свиного гриппа |
-
2010
- 2010-06-24 RU RU2012102385/10A patent/RU2560420C2/ru not_active IP Right Cessation
- 2010-06-24 MX MX2012000123A patent/MX2012000123A/es not_active Application Discontinuation
- 2010-06-24 BR BRPI1014844A patent/BRPI1014844A2/pt not_active IP Right Cessation
- 2010-06-24 EP EP10792667.7A patent/EP2448598B1/en not_active Not-in-force
- 2010-06-24 NZ NZ617191A patent/NZ617191A/en not_active IP Right Cessation
- 2010-06-24 NZ NZ596823A patent/NZ596823A/xx not_active IP Right Cessation
- 2010-06-24 CA CA2766377A patent/CA2766377A1/en not_active Abandoned
- 2010-06-24 KR KR1020127000803A patent/KR20120101318A/ko not_active Ceased
- 2010-06-24 WO PCT/US2010/039826 patent/WO2010151673A1/en not_active Ceased
- 2010-06-24 US US12/822,781 patent/US8088393B2/en not_active Expired - Fee Related
- 2010-06-24 CN CN201080027726.4A patent/CN102802666B/zh not_active Expired - Fee Related
- 2010-06-24 AU AU2010266078A patent/AU2010266078B2/en not_active Ceased
- 2010-06-24 JP JP2012517731A patent/JP5745511B2/ja not_active Expired - Fee Related
- 2010-06-24 SG SG2011085669A patent/SG176178A1/en unknown
- 2010-06-24 SG SG10201403557QA patent/SG10201403557QA/en unknown
-
2011
- 2011-12-01 US US13/308,809 patent/US8715691B2/en not_active Expired - Fee Related
-
2014
- 2014-06-25 AU AU2014203458A patent/AU2014203458A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2448598A1 (en) | 2012-05-09 |
| NZ617191A (en) | 2015-06-26 |
| US8715691B2 (en) | 2014-05-06 |
| WO2010151673A1 (en) | 2010-12-29 |
| SG176178A1 (en) | 2011-12-29 |
| CA2766377A1 (en) | 2010-12-29 |
| RU2012102385A (ru) | 2013-07-27 |
| JP5745511B2 (ja) | 2015-07-08 |
| US20120244600A1 (en) | 2012-09-27 |
| US8088393B2 (en) | 2012-01-03 |
| EP2448598B1 (en) | 2016-03-30 |
| CN102802666B (zh) | 2015-06-03 |
| JP2012531205A (ja) | 2012-12-10 |
| EP2448598A4 (en) | 2013-10-23 |
| AU2010266078A1 (en) | 2011-12-22 |
| SG10201403557QA (en) | 2014-10-30 |
| RU2560420C2 (ru) | 2015-08-20 |
| AU2010266078B2 (en) | 2014-08-14 |
| NZ596823A (en) | 2013-11-29 |
| AU2014203458A1 (en) | 2014-07-17 |
| KR20120101318A (ko) | 2012-09-13 |
| US20110123559A1 (en) | 2011-05-26 |
| CN102802666A (zh) | 2012-11-28 |
| MX2012000123A (es) | 2012-03-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI1014844A2 (pt) | variantes de hemaglutinina de influenza suína. | |
| BRPI1009415A2 (pt) | escova de dentes. | |
| BRPI1012883A2 (pt) | dispositivo intercorporal. | |
| BRPI1011694A2 (pt) | similadores de categoria | |
| HRP20180429T1 (hr) | Raspršivač | |
| BRPI0925077A2 (pt) | Conjunto dispensador. | |
| FI20095433A0 (fi) | Mikroneula | |
| BRPI1016190A2 (pt) | compostos farmacêuticos. | |
| ATE546999T1 (de) | Feldspritze | |
| BRPI1014802A2 (pt) | pró-fármacos de triptolida. | |
| IT1393854B1 (it) | Dispenser. | |
| IT1396487B1 (it) | Convogliatore. | |
| BR112013012815A2 (pt) | solução aquosa de ambroxol | |
| BRPI1016192A2 (pt) | derivados de soxazol. | |
| DK2417016T3 (da) | Spulesystem | |
| IT1395956B1 (it) | Dispenser. | |
| DK2422810T3 (da) | Influenzavaccine | |
| BRPI1016245A2 (pt) | Preparação de c-pirazina-metilaminas. | |
| BR112012000565A2 (pt) | ensaio de vírus. | |
| BRPI1008549A2 (pt) | variantes de neuraminidase e hemaglutinina de influenza | |
| DK2281424T3 (da) | Jordbearbejdingsindretning. | |
| BRPI1008680A2 (pt) | pé de suporte. | |
| IT1396874B1 (it) | Macchina etichettatrice. | |
| EP2485753A4 (en) | VARIANTS OF THE CHAPERONINE IN POSITION 10 | |
| IT1394461B1 (it) | Dispositivo spollonatore. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |